Books in Pharmaceutical sciences

1-10 of 466 results in All results

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

2nd Edition
Ali S. Faqi
Ali S. Faqi
November 3, 2016

Hardback
9 7 8 - 0 - 1 2 - 8 0 3 6 2 0 - 4
eBook
9 7 8 - 0 - 1 2 - 8 0 3 6 2 1 - 1

A Comprehensive Guide to Toxicology in Nonclinical Drug Development, Second Edition, is a valuable reference designed to provide a complete understanding of all aspects of nonclinical toxicology in the development of small molecules and biologics. This updated edition has been reorganized and expanded to include important topics such as stem cells in nonclinical toxicology, inhalation and dermal toxicology, pitfalls in drug development, biomarkers in toxicology, and more. Thoroughly updated to reflect the latest scientific advances and with increased coverage of international regulatory guidelines, this second edition is an essential and practical resource for all toxicologists involved in nonclinical testing in industry, academic, and regulatory settings.

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

3rd Edition
Ali S. Faqi
Ali S. Faqi
January 1, 2024

Hardback
9 7 8 - 0 - 3 2 3 - 8 5 7 0 4 - 8
eBook
9 7 8 - 0 - 3 2 3 - 9 8 4 6 2 - 1

A Comprehensive Guide to Toxicology in Nonclinical Drug Development, Third Edition is a valuable reference providing a complete understanding of all aspects of nonclinical toxicology in pharmaceutical research. This updated edition has been expanded and re-developed covering a wide-range of toxicological issues in small molecules and biologics. Topics include ADME in drug discovery, pharmacokinetics, toxicokinetics, formulations, and genetic toxicology testing. The book has been thoroughly updated throughout to reflect the latest scientific advances and includes new information on antiviral drugs, anti-diabetic drugs, immunotherapy, and a discussion on post-pandemic drug development challenges and opportunities. This is an essential and practical resource for all toxicologists involved in nonclinical testing in industry, academic, and regulatory settings.

A Comprehensive Guide to Toxicology in Preclinical Drug Development

1st Edition
Ali S. Faqi
Ali S. Faqi
October 18, 2012

Hardback
9 7 8 - 0 - 1 2 - 3 8 7 8 1 5 - 1
eBook
9 7 8 - 0 - 1 2 - 3 8 7 8 1 6 - 8

A Comprehensive Guide to Toxicology in Preclinical Drug Development is a resource for toxicologists in industry and regulatory settings, as well as directors working in contract resource organizations, who need a thorough understanding of the drug development process. Incorporating real-life case studies and examples, the book is a practical guide that outlines day-to-day activities and experiences in preclinical toxicology. This multi-contributed reference provides a detailed picture of the complex and highly interrelated activities of preclinical toxicology in both small molecules and biologics. The book discusses discovery toxicology and the international guidelines for safety evaluation, and presents traditional and nontraditional toxicology models. Chapters cover development of vaccines, oncology drugs, botanic drugs, monoclonal antibodies, and more, as well as study development and personnel, the role of imaging in preclinical evaluation, and supporting materials for IND applications. By incorporating the latest research in this area and featuring practical scenarios, this reference is a complete and actionable guide to all aspects of preclinical drug testing.

Image - A Comprehensive Guide to Toxicology in Preclinical Drug Development

A Handbook of Artificial Intelligence in Drug Delivery

1st Edition
Anil K. Philip, Aliasgar Shahiwala + 2 more
Anil K. Philip, Aliasgar Shahiwala, Mamoon Rashid + 1 more
March 27, 2023

Paperback
9 7 8 - 0 - 3 2 3 - 8 9 9 2 5 - 3
eBook
9 7 8 - 0 - 3 2 3 - 9 0 3 7 3 - 8

A Handbook of Artificial Intelligence in Drug Delivery explores the use of Artificial Intelligence (AI) in drug delivery strategies. The book covers pharmaceutical AI and drug discovery challenges, Artificial Intelligence tools for drug research, AI enabled intelligent drug delivery systems and next generation novel therapeutics, broad utility of AI for designing novel micro/nanosystems for drug delivery, AI driven personalized medicine and Gene therapy, 3D Organ printing and tissue engineering, Advanced nanosystems based on AI principles (nanorobots, nanomachines), opportunities and challenges using artificial intelligence in ADME/Tox in drug development, commercialization and regulatory perspectives, ethics in AI, and more. This book will be useful to academic and industrial researchers interested in drug delivery, chemical biology, computational chemistry, medicinal chemistry and bioinformatics. The massive time and costs investments in drug research and development necessitate application of more innovative techniques and smart strategies.

Image - A Handbook of Artificial Intelligence in Drug Delivery

A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy

1st Edition
Mariappan Rajan
Mariappan Rajan
March 15, 2021

Paperback
9 7 8 - 0 - 1 2 - 8 1 9 9 8 5 - 5
eBook
9 7 8 - 0 - 1 2 - 8 2 4 4 8 4 - 5

A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy examines drug carrier development for controlled, targeted, pH and stimuli responsive drug releases for tuberculosis. The book provides in-depth information about mycobacterium tuberculosis, tuberculosis formation, and synthetic procedures for carrier synthesis, characterizations and mechanistic approaches. Key topics include the properties and functions of nanomedicines and how they might be applied for clinical diagnosis and treatment. Emphasis is placed on the basic fundamentals, biomaterial formulations, design principles, fabrication techniques, and transitioning bench-to-bed clinical applications. This book is useful for new researchers who focus on nanomedicine, stem cell therapy and bone tissue engineering. In addition, it introduces experienced researchers and clinicians to key trends, thus increasing their knowledge in drug discovery for tuberculosis and nanomedicine.

Image - A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy

A Pharmacology Primer

5th Edition
Terry P. Kenakin
Terry P. Kenakin
October 26, 2018

Paperback
9 7 8 - 0 - 1 2 - 8 1 3 9 5 7 - 8
eBook
9 7 8 - 0 - 1 2 - 8 1 3 9 5 8 - 5

A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery, Fifth Edition features the latest ideas and research regarding the application of pharmacology to the process of drug discovery. Written by well-respected pharmacologist, Terry P. Kenakin, this primer is an indispensable resource for all those involved in drug discovery. This updated edition has been thoroughly revised to include material on quantifying drug efficacy through bias and cluster analysis, the impact of molecular dynamics and protein structural analysis, the real time kinetic analysis of drug effect, virtual screening for new drug chemical scaffolds, and much more. With full color illustrations and new examples throughout, this book remains a top reference for all industry and academic scientists that is also ideal for students directly involved in drug discovery or pharmacologic research.

A Pharmacology Primer

6th Edition
Terry P. Kenakin
Terry P. Kenakin
August 14, 2022

Paperback
9 7 8 - 0 - 3 2 3 - 9 9 2 8 9 - 3
eBook
9 7 8 - 0 - 3 2 3 - 9 9 2 9 0 - 9

A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery, Sixth Edition features the latest research surrounding the application of pharmacology in drug discovery in an effort to equip readers with a deeper understanding of complex and rapid changes in this field. Written by well-respected pharmacologist, Terry P. Kenakin, this primer is an indispensable resource for anyone involved in drug discovery. This edition has been reorganized for better flow and clarity and includes material on new technologies for screening (virtual, DNA encoded libraires, fragment-based) and a major section on phenotypic (target agnostic) screening for new leads and determination of drug targets. With full color illustrations as well as new examples throughout, this book remains a top reference for all industry and academic scientists and students directly involved in drug discovery or pharmacologic research. New material includes a discussion of the determination of target engagement, including numerous new ways to demonstrate the physical interaction of molecules with drug targets and new drug candidates such a mRNA, gene therapy, antibodies and information on CRISPR and genomics.

A Practical Guide to Rational Drug Design

1st Edition
Sun Hongmao
Sun Hongmao
October 1, 2015

Hardback
9 7 8 - 0 - 0 8 - 1 0 0 0 9 8 - 4
eBook
9 7 8 - 0 - 0 8 - 1 0 0 1 0 5 - 9

This book is not going to be an exhaustive survey covering all aspects of rational drug design. Instead, it is going to provide critical know-how through real-world examples. Relevant case studies will be presented and analyzed to illustrate the following: how to optimize a lead compound whether one has high or low levels of structural information; how to derive hits from competitors’ active compounds or from natural ligands of the targets; how to springboard from competitors’ SAR knowledge in lead optimization; how to design a ligand to interfere with protein-protein interactions by correctly examining the PPI interface; how to circumvent IP blockage using data mining; how to construct and fully utilize a knowledge-based molecular descriptor system; how to build a reliable QSAR model by focusing on data quality and proper selection of molecular descriptors and statistical approaches. A Practical Guide to Rational Drug Design focuses on computational drug design, with only basic coverage of biology and chemistry issues, such as assay design, target validation and synthetic routes.

Image - A Practical Guide to Rational Drug Design

Accelerated Predictive Stability (APS)

1st Edition
Fenghe Qiu + 1 more
Fenghe Qiu and Garry Scrivens
May 14, 2018

Hardback
9 7 8 - 0 - 1 2 - 8 0 2 7 8 6 - 8
eBook
9 7 8 - 0 - 1 2 - 8 0 2 7 8 5 - 1

Accelerated Predictive Stability (APS): Fundamentals and Pharmaceutical Industry Practices provides coverage of both the fundamental principles and pharmaceutical industry applications of the APS approach. Fundamental chapters explain the scientific basis of the APS approach, while case study chapters from many innovative pharmaceutical companies provide a thorough overview of the current status of APS applications in the pharmaceutical industry. In addition, up-to-date experiences in utilizing APS data for regulatory submissions in many regions and countries highlight the potential of APS in support of registration stability testing for certain regulatory submissions. This book provides high level strategies for the successful implementation of APS in a pharmaceutical company. It offers scientists and regulators a comprehensive resource on how the pharmaceutical industry can enhance their understanding of a product’s stability and predict drug expiry more accurately and quickly.

Image - Accelerated Predictive Stability (APS)

Actinomycetes in Biotechnology

1st Edition
Bozzano G Luisa
Bozzano G Luisa
January 28, 1988

eBook
9 7 8 - 0 - 0 8 - 0 9 8 4 3 3 - 9

The actinomycetes are a group of bacteria well known as producers of antibiotics. With the advent of molecular biology they have become important to biotechnologists in the search for new antibiotics, vitamins, enzyme inhibitors, etc. They also play an important role in the biodegradation of wastes, and their wide (natural) distribution in soil, composts, water and elsewhere in the environment makes them important to the agricultural and waste industries. This research book presents a broad view of the current interest in actinomycetes, ranging from isolation/screening of actinomycetes, discovery of new antibiotics, a substantial contribution on genetic manipulation to actinomycetes in agriculture, forestry, and the threat of actinomycetes as pollutants in the environment.The chapters, which have been written by experts, are intended to provide a balanced view of the opportunities and problems in an expanding field of interest.